Neurobiological Technologies Valuation
| NTII Stock | USD 0.0001 0.00 0.00% |
Neurobiological Technologies seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Neurobiological Technologies from analyzing the firm fundamentals such as Operating Margin of 0.77 %, shares outstanding of 27.02 M, and Return On Equity of 1.0 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Neurobiological Technologies' valuation include:
Price Book 0.0655 | Enterprise Value | Enterprise Value Ebitda 0.4688 | Price Sales 0.0001 | Enterprise Value Revenue 0.1885 |
Overvalued
Today
Please note that Neurobiological Technologies' price fluctuation is very steady at this time. Calculation of the real value of Neurobiological Technologies is based on 3 months time horizon. Increasing Neurobiological Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Neurobiological Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neurobiological Stock. However, Neurobiological Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Neurobiological Technologies' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Neurobiological Technologies' stock price.
Estimating the potential upside or downside of Neurobiological Technologies helps investors to forecast how Neurobiological stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neurobiological Technologies more accurately as focusing exclusively on Neurobiological Technologies' fundamentals will not take into account other important factors: When choosing an evaluation method for Neurobiological Technologies, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Neurobiological Technologies Cash |
|
About Neurobiological Technologies Valuation
An absolute valuation paradigm, as applied to Neurobiological Stock, attempts to find the value of Neurobiological Technologies based on its fundamental and basic technical indicators. By analyzing Neurobiological Technologies's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Neurobiological Technologies's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neurobiological Technologies. We calculate exposure to Neurobiological Technologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neurobiological Technologies's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6.9 M | 6.6 M | |
| Pretax Profit Margin | 0.12 | 0.11 | |
| Operating Profit Margin | 0.12 | 0.13 | |
| Net Profit Margin | 0.12 | 0.11 | |
| Gross Profit Margin | 0.90 | 0.77 |
Neurobiological Technologies Current Valuation Indicators
Valuation refers to the process of determining the present value of Neurobiological Technologies and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Neurobiological we look at many different elements of the entity such as Neurobiological's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Neurobiological Technologies, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Neurobiological Technologies' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Neurobiological Technologies' worth.Complementary Tools for Neurobiological Stock analysis
When running Neurobiological Technologies' price analysis, check to measure Neurobiological Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurobiological Technologies is operating at the current time. Most of Neurobiological Technologies' value examination focuses on studying past and present price action to predict the probability of Neurobiological Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurobiological Technologies' price. Additionally, you may evaluate how the addition of Neurobiological Technologies to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |